Dr Reddys Laboratories annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories reported $3.81B in revenue for fiscal 2025, an increase of 13.76% from the previous fiscal year.
View full Dr Reddys Laboratories company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | $3.81B | $461.0M | +13.76% |
| 2024 | 2024-03-31 | $3.35B | $358.0M | +11.97% |
| 2023 | 2023-03-31 | $2.99B | $166.0M | +5.87% |
| 2022 | 2022-03-31 | $2.83B | $232.0M | +8.94% |
| 2021 | 2021-03-31 | $2.59B | $278.0M | +12.00% |
| 2020 | 2020-03-31 | $2.32B | $91.0M | +4.09% |
| 2019 | 2019-03-31 | $2.23B | $44.0M | +2.02% |
| 2018 | 2018-03-31 | $2.18B | — | — |
Over the last five reported fiscal years, revenue grew from $2.32B to $3.81B, a compound annual growth rate of 10.47%.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Dr Reddys Laboratories source filings ↗